EXOZ eXoZymes, Inc.
USHealthcareAs of 2026-07-02
Why EXOZ matters now
eXoZymes, Inc. (EXOZ) is a US stock in Healthcare. The latest InvestLog snapshot shows $8.48 with -0.24% on the session and $78.7M in market capitalization; recent performance reads 1-month -17.58% and YTD -28.17%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-2.4M, and EPS of $-0.28. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -10.7%.
The latest indexable market news headline is "eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery" from Accesswire.
Additional event context on this page matters because recent insider activity includes Korman Tyler Paz filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
43.34
P/S
0.00
EV/EBITDA
-6.72
DCF Value
$0.14
FCF Yield
-10.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-220.6%
ROA
-240.7%
ROIC
-362.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $-2.4M | $-0.28 |
| Q4 2025 | $0.00 | $-2.7M | $-0.32 |
| FY 2025 | $0.00 | $-9.2M | $-1.09 |
| Q3 2025 | $0.00 | $-2.3M | $-0.27 |
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
2.66
Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals. This output encompasses essential pharmaceuticals, alternative fuels, advanced materials, food additives, and entirely new molecular entities. Integral to its design, the SimplePath platform incorporates distinct modules, each housing one or more enzymes that work synergistically to facilitate specific biocatalytic transformations. The firm was established in 2014 and maintains its corporate headquarters in Monrovia, California.